Literature DB >> 34116589

Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients.

Giuseppe Lippi1, Brandon M Henry2, Emmanuel J Favaloro3.   

Abstract

Entities:  

Keywords:  COVID-19; coronavirus; soluble urokinase plasminogen activator receptor; suPAR

Year:  2021        PMID： 34116589     DOI： 10.1515/cclm-2021-0561

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  2 in total

1.  Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failure.

Authors:  Evangelos J Giamarellos-Bourboulis; Garyfallia Poulakou; Aline de Nooijer; Haralampos Milionis; Simeon Metallidis; Michalis Ploumidis; Pinelopi Grigoropoulou; Aggeliki Rapti; Francesco Vladimiro Segala; Evangelos Balis; Efthymia Giannitsioti; Paola Rodari; Ilias Kainis; Zoi Alexiou; Emanuele Focà; Brollo Lucio; Nikoletta Rovina; Laura Scorzolini; Maria Dafni; Sofia Ioannou; Alessandro Tomelleri; Katerina Dimakou; Glykeria Tzatzagou; Maria Chini; Matteo Bassetti; Christina Trakatelli; George Tsoukalas; Carlo Selmi; Charilaos Samaras; Maria Saridaki; Athina Pyrpasopoulou; Elisabeth Kaldara; Ilias Papanikolaou; Aikaterini Argyraki; Karolina Akinosoglou; Marina Koupetori; Periklis Panagopoulos; George N Dalekos; Mihai G Netea
Journal:  Cell Rep Med       Date:  2022-02-25

Review 2.  The role of kidney injury biomarkers in COVID-19.

Authors:  Lianjiu Su; Jiahao Zhang; Zhiyong Peng
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.